Hologic Inc (HOLX) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Dec 27 2025 to Dec 28 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Hologic Inc  (NASDAQ: HOLX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Hologic Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Hologic Inc's ROI in the first quarter of 2026?
Hologic Inc achieved a return on average invested assets (ROI) of 7.3 % in its first quarter of 2026, this is above HOLX's average return on investment of 5.46%.
Hologic Incs investments during the 12 months ending in the first quarter of 2026 are valued at $7 billion

ROI decreased relative to the period ending Sep 27 2025, due to the decline in net income.

Within the Healthcare sector 162 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 867 to 1342.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 27 2025)
I. Quarter		 (Sep 27 2025)
IV. Quarter		 (Jun 28 2025)
III. Quarter		 (Mar 29 2025)
II. Quarter		 (Dec 28 2024)
I. Quarter
Y / Y Investment Change TTM 0.1 % -1.31 % -0.8 % -2.13 % -3.56 %
Y / Y Net Income Change TTM -26.91 % -28.35 % -8.81 % 33.69 % 201.83 %
Investment (TTM) in Millions 7,760 7,565 7,364 7,092 7,265
Return On Investment (TTM) 7.3 % 7.73 % 7.59 % 7.56 % 10 %
HOLX's Overall Ranking # 1342 # 867 # 680 # 636 # 145
Seq. Investment Change TTM 1.69 % -0.26 % -0.37 % -0.94 % 0.25 %
Seq. Net Income Change TTM -3.87 % 1.54 % 0.07 % -25.17 % -5.76 %
Net Income (TTM) in Millions 544 566 557 557 744

HOLX Company Profile >> Back to HOLX Roi Comparisons >> See Annual HOLX Return On Investment



Return On Investment HOLX's Ranking
Within: No.
Industry # 9
Sector # 163
Overall # 1342

Return On Investment Statistics
High Average Low
30.7 %
5.46 %
-13.55 %
(Jun 26 2021)   (Jun 28 2014)







Financial Statements
Hologic Inc's I. Quarter Investments $ 7,760 Millions HOLX's Balance sheet
Hologic Inc's I. Quarter Income $ 179 Millions Quarterly HOLX's Income Statement
HOLX's Income by Division See HOLX's Income by Division


HOLX Annual Return On Investment (Sep 27 2025)
2025		 (Sep 28 2024)
2024		 (Sep 30 2023)
2023		 (Sep 24 2022)
2022		 (Sep 25 2021)
2021
Total Investments in Millions 7,565 7,641 7,562 7,694 7,593
Y / Y Investment Growth -0.99 % 1.04 % -1.72 % 1.33 % 31.9 %
Net Income in Millions 566 790 456 1,302 1,870
Y / Y Net Income Growth -28.35 % 73.14 % -64.98 % -30.36 % 68.37 %
Annual Return On Investment 7.48 % 10.33 % 6.03 % 16.92 % 24.62 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 7.48 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HOLX's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HOLX's Competitors
Subscribers only: Roi for Hologic Inc's Suppliers
Subscribers only: Return On Investment for HOLX's Customers

Other Ratios
HOLX's Roa HOLX's Inventory Turnover Ratio HOLX's Growth Rates HOLX's Dividend Statistics
HOLX's Profitability Ratios HOLX's Asset Turnover Ratio HOLX's Dividend Growth
HOLX's Roe HOLX's Valuation Ratios HOLX's Financial Strength Ratios HOLX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 27 2025, within Healthcare Sector ROI
Astrazeneca Plc  19.67 %
Vertex Pharmaceuticals Inc  19.48 %
Inspire Medical Systems inc   19.34 %
Mimedx Group Inc   19.27 %
Gilead Sciences Inc   19.26 %
United Therapeutics Corporation  18.71 %
Krystal Biotech Inc   18.51 %
Agilent Technologies inc   18.50 %
Chemed Corporation  18.05 %
Hca Healthcare Inc   17.95 %
Sbc Medical Group Holdings Incorporated  17.85 %
Lifevantage Corp  17.77 %
Embecta Corp   17.69 %
Waters Corporation  17.39 %
Spero Therapeutics Inc   16.92 %
Johnson and Johnson  16.85 %
Halozyme Therapeutics Inc   16.47 %
Intuitive Surgical Inc   15.81 %
Black Diamond Therapeutics Inc   15.47 %
Strata Critical Medical Inc   15.07 %
Aveanna Healthcare Holdings Inc   14.96 %
Ironwood Pharmaceuticals inc   14.88 %
Argenx Se  14.81 %
Corcept Therapeutics Inc  14.64 %
Harmony Biosciences Holdings inc   14.44 %
Keros Therapeutics Inc   13.88 %
Sab Biotherapeutics Inc   13.87 %
West Pharmaceutical Services Inc   13.68 %
Inmode Ltd   13.49 %
Neurocrine Biosciences Inc   13.45 %

Date modified: 2026-09-26T06:54:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.